Microbiología y Parasitología
Departamento
University of Bologna
Bolonia, ItaliaPublicaciones en colaboración con investigadores/as de University of Bologna (12)
2021
-
Time to first antibiotic dose for community-acquired pneumonia: a challenging balance
Clinical Microbiology and Infection
2018
-
A prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients
Clinical Microbiology and Infection, Vol. 24, Núm. 5, pp. 546.e1-546.e8
-
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
Clinical Microbiology and Infection, Vol. 24, pp. e1-e38
2017
-
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
The Lancet Infectious Diseases, Vol. 17, Núm. 7, pp. 726-734
-
Geographical variation in therapy for bloodstream infections due to multidrug-resistant Enterobacteriaceae: a post-hoc analysis of the INCREMENT study
International Journal of Antimicrobial Agents, Vol. 50, Núm. 5, pp. 664-672
2016
-
A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae
Mayo Clinic Proceedings, Vol. 91, Núm. 10, pp. 1362-1371
-
A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae
Antimicrobial Agents and Chemotherapy, Vol. 60, Núm. 7, pp. 4159-4169
-
Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: A multinational pre-registered cohort study
Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 6, pp. 1672-1680
2015
-
How much European prescribing physicians know about invasive fungal infections management?
BMC Infectious Diseases, Vol. 15, Núm. 1
-
Individualizing risk of multidrug-resistant pathogens in community-onset pneumonia
PLoS ONE, Vol. 10, Núm. 4
2014
2007
-
Liposomal amphotericin B as initial therapy for invasive mold infection: A randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad Trial)
Clinical Infectious Diseases, Vol. 44, Núm. 10, pp. 1289-1297